Jump to content

ADSHG Newsletter 121 - September 2015


1 Screenshot

About this Publication

Addison's Disease Self Help Group newsletter, issue 121, September 2015

 

Welcome to the autumn 2015 newsletter. This issue starts with a controversial topic: on page 3, we respond to recent claims from The Times columnist Tanya Byron about the psychological health of people with Addison’s. Perhaps because she has only a passing familiarity with the effects of high-dose prednisolone, Prof Byron seems unaware of the difference between the side effects from therapeutic steroid doses that may be more than ten times higher than replacement, and the restorative, life-saving benefits of replacement hydrocortisone.

 

Page 1: Front page
Because steroids are for life
Mistaken media views on Addison's
Efcortesol update

 

Page 2: From the President
About the money

 

Page 3: In the media
Media comments on adrenal insufficiency and mental health: the ADSHG viewpoint

 

Pages 4-5: Personal experience
Nathan Gafuik: Crisis in Moscow
Happy to inject!

 

Page 6: Irish news
Addison's Ireland news
ADSHG at European Congress of Endocrinology

 

Pages 7-9: ADSHG Annual Report 2014
Chair's report to the AGM
A day in the capital
Treasurer's report
Publications & media team report

 

Pages 10-11: Around the group
What's new with flu?
Join our letter writing campaign
Alfred Potter memorial medical research award
Update: out-of-date Medic Exempt fines
Are you red flagged?
Pharmacy labels

 

Page 12: Personal experience
Why feedback to ambulance trusts is important: my experience
Paramedics: the frontline perspective

 

Page 13: Fundraising reports
Ian's £undraising update

 

Pages 14-15: Social reports
Jan's social corner
Wibbly Wobbly Webby
2015 social & medical meetings

 

Page 16: Back page
Reminders
2015 subscription rates


×
×
  • Create New...

Important Information

By using this website you are consenting to the use of cookies. Details about their use and how you can adjust your cookie settings are described in our cookie statement.